Senestech, Inc. (NASDAQ:SNES) Short Interest Up 153.4% in July

Posted by Geri Gentry on Aug 16th, 2026

Senestech, Inc. (NASDAQ:SNES – Get Free Report) was the recipient of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 69,945 shares, an increase of 153.4% from the July 15th total of 27,608 shares. Approximately 1.3% of the company’s shares are sold short. Based on an average daily trading volume, of 45,135 shares, the short-interest ratio is currently 1.5 days.

Insider Buying and Selling at Senestech

In related news, major shareholder Glenbrook Capital Management bought 35,000 shares of the stock in a transaction dated Monday, July 20th. The stock was bought at an average price of $1.47 per share, with a total value of $51,450.00. Following the purchase, the insider owned 1,057,824 shares in the company, valued at approximately $1,555,001.28. The trade was a 3.42% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Over the last three months, insiders bought 140,143 shares of company stock valued at $210,181. Insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On Senestech

Several institutional investors and hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC bought a new stake in shares of Senestech in the 2nd quarter worth approximately $59,000. Jane Street Group LLC bought a new position in shares of Senestech during the second quarter valued at approximately $161,000. Millennium Management LLC bought a new position in shares of Senestech during the third quarter valued at approximately $126,000. Diversify Advisory Services LLC purchased a new stake in Senestech in the fourth quarter worth $34,000. Finally, Renaissance Technologies LLC lifted its stake in Senestech by 35.2% in the fourth quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock worth $306,000 after acquiring an additional 37,165 shares during the period. Hedge funds and other institutional investors own 5.19% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Check Out Our Latest Stock Analysis on SNES

Senestech Price Performance

SNES stock opened at $1.21 on Friday. The firm’s 50-day moving average price is $1.47 and its two-hundred day moving average price is $1.69. Senestech has a 12-month low of $1.15 and a 12-month high of $5.35. The stock has a market capitalization of $6.56 million, a price-to-earnings ratio of -0.88 and a beta of 0.28. The company has a current ratio of 6.78, a quick ratio of 5.81 and a debt-to-equity ratio of 0.02.

Senestech (NASDAQ:SNES – Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.02. The company had revenue of $0.77 million during the quarter, compared to analyst estimates of $0.60 million. Senestech had a negative net margin of 294.73% and a negative return on equity of 71.89%. As a group, equities analysts predict that Senestech will post -1.28 earnings per share for the current year.

Senestech Company Profile

(Get Free Report)

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.